(Q30279074)

4 October 2017

GITR agonist enhances vaccination responses in lung cancer (English)

1 reference

4 October 2017

Li X Zhu

1

1 reference

4 October 2017

Michael Davoodi

2

1 reference

4 October 2017

Minu K Srivastava

3

1 reference

4 October 2017

Puja Kachroo

4

1 reference

4 October 2017

Jay M Lee

5

1 reference

4 October 2017

Maie St John

6

1 reference

4 October 2017

Marni Harris-White

7

1 reference

4 October 2017

Min Huang

8

1 reference

4 October 2017

Robert M Strieter

9

1 reference

4 October 2017

Steven Dubinett

10

1 reference

4 October 2017

Sherven Sharma

11

1 reference

4 October 2017

27 April 2015

1 reference

4 October 2017

1 reference

4 October 2017

4

1 reference

4 October 2017

4

1 reference

4 October 2017

e992237

1 reference

Nivolumab plus ipilimumab in advanced melanoma

4 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

3 June 2018

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

Glucocorticoid-induced TNF receptor, a costimulatory receptor on naive and activated T cells, uses TNF receptor-associated factor 2 in a novel fashion as an inhibitor of NF-kappa B activation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

Immunosuppressive networks in the tumour environment and their therapeutic relevance

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485739

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

3 June 2018

1 reference

https://api.crossref.org/works/10.4161%2F2162402X.2014.992237

Glucocorticoid-induced TNF receptor functions as a costimulatory receptor that promotes survival in early phases of T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2F2162402X.2014.992237

IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2F2162402X.2014.992237

Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2F2162402X.2014.992237

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2F2162402X.2014.992237

Clinical significance of defective dendritic cell differentiation in cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26137407

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immune cell infiltrates and prognosis in primary carcinoma of the lung

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26137407

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26137407

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/2162402X.2014.992237

1 reference

4 October 2017

1 reference

4 October 2017

1 reference